Oct 12 close
Hawkins draws attention this week mainly around its approaching fiscal 2027 second-quarter results, scheduled for release on 26 October 2026 after market close, with analysts anticipating earnings of $1.21 per share on revenue of $302.70 million. The upcoming report follows a first quarter in which revenue beat forecasts but diluted EPS missed expectations, framing this release as a test of the company's expansion strategy. Separately, Argus raised its price target on Hawkins to $145.00, citing strong performance across the company's chemicals and ingredients segments, while a comparison piece weighed Hawkins against Eastman Chemical on dividends, risk and valuation.
Hawkins closed at $130.42, up 0.3%, sitting between its 50-day average of $126.24 and its 200-day average of $144.05. The one-month return stands at 5.1%, though three-month, six-month and one-year returns remain negative at -5.7%, -13.2% and -23.6% respectively. The GekkoIndex reads 54.6, placing the stock in the Neutral zone, and price sits 19.5% below Gekko Fair Value of $162.09.
Earnings arrive on 26 October 2026, 14 days away, falling inside a typical 20-trading-day holding window; the last report saw EPS of $1.35 against a $1.39 estimate and a -9.6% reaction. Over the last 90 days, 2 insider purchases totaling $261,576 were recorded. Seasonally, the next 20 trading days have averaged -3.9% over 5 years, with gains in 3 of them. Two analysts cover the stock, one buy and one hold, with a consensus target of $174.25.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Hawkins scores 2 supportive, 3 mixed and 1 headwind across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive3 mixed1 headwind
Averages disagree
Close $130.42 sits between the 50-day ($126.24) and 200-day ($144.05) averages, or the averages disagree.
See the chart54.6, Neutral
Reading 54.6 is in the Neutral zone.
See the GekkoIndex19.5% below
Price is 19.5% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 90 days: 2 open-market insider purchases.
See smart moneyReports in 14 days
Reports on Oct 26, 2026, 14 days away — inside a typical 20-trading-day hold.
See earnings−3.9% on average
From this point in the calendar, the next 20 trading days averaged −3.9% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Hawkins closed at $130.42 on Oct 12, 2026, −23.6% over the past year, inside a 52-week range of $116.05 to $176.58.
Use the left and right arrow keys to read daily values.
Put HWKN on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Hawkins makes, blends, and distributes chemicals and specialized ingredients for customers at home and abroad. It is probably best recognized for its broad chemical supply work, which reaches industries such as agriculture, electronics, energy, food, pharmaceuticals, and plating with products ranging from acids and alkaline compounds to food-grade and pharmaceutical-quality salts.
The business runs through three divisions. The Industrial group handles bulk chemicals like caustic soda, sulfuric and hydrochloric acid, urea, and potassium hydroxide, alongside manufacturing of sodium hypochlorite and custom blends, plus repackaging and private-label bleach services. The Water Treatment division supplies chemicals, equipment, and solutions for drinking water, wastewater, process water, and water used in pools and agriculture. The Health and Nutrition division sources, processes, and formulates ingredients such as minerals, botanicals, vitamins, amino acids, excipients, and sweeteners for makers of nutraceuticals, functional foods, supplements, and personal care goods.
Founded in 1938, Hawkins is headquartered in Roseville, Minnesota. Its shares trade on the NASDAQ under the ticker HWKN.
Hawkins’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 54.6, in the Neutral zone, up 3.1 points over five sessions.
Up 3.1 points over five sessions.
Reading for Oct 12, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 43 | +4.7% | +7.4% | ||
| Accumulation | 164 | −0.4% | +0.1% | ||
| Neutral (current zone) | 431 | +0.8% | +2.9% | ||
| Distribution | 40 | −0.8% | +4.3% | ||
| Selling | 4 | Too few readings yet | |||
Average HWKN share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Hawkins trades 19.5% below Gekko Fair Value of $162.09, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Hawkins shares are worth, recalculated every trading day.
$162.09
Gekko Fair Value, Oct 10, 2026
19.5% Undervalued
At the end of Aug 2026 the price was 28.7% below the estimate.
Insiders filed 2 open-market purchases in Hawkins worth $262K, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
$262Kin 2 open-market purchases
| Filed | Insider | Type | Value |
|---|---|---|---|
| Aug 31 | Oldenkamp Jeffrey P. officer: EXECUTIVE VP AND CFO | Purchase | $154K |
| Aug 27 | Lange Douglas A. officer: VP - WATER TREATMENT GROUP | Purchase | $108K |
From Form 4 filings, dated to when each was filed.
No trades in HWKN were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Hawkins has been buying back its own shares.
From company filings.
Hawkins reports on Oct 26, 2026 (14 days away), and beat the EPS estimate in 3 of its last 8 reports.
Oct 26, 2026
14 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 29, 2026 | $1.35 est $1.39 | $315.7M est $313.4M | −9.6% |
| May 13, 2026 | $0.74 est $0.69 | $265.9M est $255.3M | −7.1% |
| Jan 28, 2026 | $0.69 est $0.74 | $244.1M est $252.5M | −9.0% |
| Oct 29, 2025 | $1.08 est $1.24 | $280.4M est $259.9M | −8.9% |
| Jul 30, 2025 | $1.40 est $1.33 | $293.3M est $277.4M | +1.6% |
| May 14, 2025 | $0.78 est $0.74 | $245.3M est $269.2M | −1.2% |
| Jan 29, 2025 | $0.72 est $0.77 | $226.2M est $228.0M | −8.7% |
| Oct 30, 2024 | $1.16 est $1.19 | $247.0M est $259.6M | −8.8% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Hawkins is $174.25, +33.6% from the last close, from 2 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 2 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Aug 3 | BWS Financial | $200 | +53.4% |
| Jul 31 | Barclays | $142 | +8.9% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Oct 10, Hawkins averaged −3.9% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.7% | 3 of 5 |
| Next 10 trading days | −0.7% | 2 of 5 |
| Next 15 trading days | −3.1% | 1 of 5 |
| Next 20 trading days | −3.9% | 3 of 5 |
| Next 30 trading days | −3.4% | 2 of 5 |
For scale, HWKN’s typical 20-trading-day move in either direction is about 6.9%.
Hawkins’s market cap is $2.72B, with a P/E ratio of 33.1 and revenue of $1.11B over the last twelve months.
Coverage of Hawkins this week reads positive: 3 positive, 2 neutral and 0 negative headlines.
Hawkins’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| LINLinde | Neutral | 0.3% below |
| ECLEcolab | Neutral | 9.4% above |
| APDAir Products and Chemicals | Accumulation | 9.5% below |
| DOWDow | Accumulation | 33.5% below |
| LYBLyondellBasell Industries | Accumulation | 10.6% below |
| ALBAlbemarle | Accumulation | 29.6% below |
A peer links to its own page where one exists.
Hawkins’s market cap is $2.72B at the Oct 12, 2026 close of $130.42, with 20.88M shares outstanding. The shares trade on a P/E ratio of 33.1.
The consensus analyst 12-month price target for Hawkins is $174.25, +33.6% from the last close. Of the 2 firms that rated the stock in the last 90 days, 1 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Hawkins is undervalued: the Oct 12, 2026 close of $130.42 is 19.5% below Gekko Fair Value of $162.09. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Hawkins is expected to report on Oct 26, 2026 (14 days away). Analysts expect earnings of $1.21 per share on revenue of $302.7M. Hawkins beat the earnings estimate in 3 of its last 8 reports, moving 6.9% on average across the report.
Hawkins’s 52-week high is $176.58 and its 52-week low is $116.05; it closed at $130.42 on Oct 12, 2026, −23.6% over the past year. Over the last five years the shares peaked at $186.15 on Oct 6, 2025.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 6 items with data read as supportive (fair value and smart money), 3 as mixed (trend, gekkoindex and seasonality) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.